This EASL Studio episode brings key insights from the 2025 EASL–AASLD Consensus Conference on Primary Biliary Cholangitis (PBC). Experts explore the use of surrogate endpoints, the challenges in current trial design and regulation, the value of real-world evidence, and how quality-of-life assessment can support future pathways. Moderator: David Jones Speakers: Marco Carbone, Bettina Hansen, and Ana Lleo All EASL Studio Podcasts are available on EASL Campus. Click here to see all EASL Vide...
All content for EASL Podcasts is the property of European Association for the Study of the Liver and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
This EASL Studio episode brings key insights from the 2025 EASL–AASLD Consensus Conference on Primary Biliary Cholangitis (PBC). Experts explore the use of surrogate endpoints, the challenges in current trial design and regulation, the value of real-world evidence, and how quality-of-life assessment can support future pathways. Moderator: David Jones Speakers: Marco Carbone, Bettina Hansen, and Ana Lleo All EASL Studio Podcasts are available on EASL Campus. Click here to see all EASL Vide...
EASL Studio Podcast: Rifaximin for Hepatic Encephalopathy: Balancacing Benefits and Risks in the Era of Antimicrobial Resistance
EASL Podcasts
36 minutes
1 month ago
EASL Studio Podcast: Rifaximin for Hepatic Encephalopathy: Balancacing Benefits and Risks in the Era of Antimicrobial Resistance
For World Antimicrobial Awareness Week 2025 (“Act Now: Protect Our Present, Secure Our Future”), this EASL Studio explores the balance between rifaximin’s benefits in hepatic encephalopathy and the global challenge of antimicrobial resistance. Moderator: Debbie Shawcross Speakers: Rajiv Jalan, Vishal Patel, Jonel Trebicka All EASL Studio Podcasts are available on EASL Campus. Click here to see all EASL Video Podcasts on Apple Podcasts. This EASL Studio is supported by Alfasigma and Norgine....
EASL Podcasts
This EASL Studio episode brings key insights from the 2025 EASL–AASLD Consensus Conference on Primary Biliary Cholangitis (PBC). Experts explore the use of surrogate endpoints, the challenges in current trial design and regulation, the value of real-world evidence, and how quality-of-life assessment can support future pathways. Moderator: David Jones Speakers: Marco Carbone, Bettina Hansen, and Ana Lleo All EASL Studio Podcasts are available on EASL Campus. Click here to see all EASL Vide...
